Search research articles
Contact Us
Filters
Showing results (31-40 of 62) with videos related to
Page
of 7
Sort By:
Antiviral Therapy
|
February 2, 2012
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment
Ingmar Mederacke, Cihan Yurdaydin, George N Dalekos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 1, 2018
Systemic inflammation and immune cell phenotypes are associated with neuro-psychiatric symptoms in patients with chronic inflammatory liver diseases
Amare Aregay, Meike Dirks, Verena Schlaphoff, et al.
Gut
|
April 12, 2014
Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals
Sebastian Lunemann, David F G Malone, Jan Grabowski, et al.
Gut
|
May 26, 2016
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome
Daniel Todt, Anett Gisa, Aleksandar Radonic, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 14, 2019
Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a
Franziska Rinker, Corinna M Bremer, Kathrin Schröder, et al.
Scientific Reports
|
April 2, 2020
Author Correction: Development and performance of prototype serologic and molecular tests for hepatitis delta infection
Kelly E Coller, Emily K Butler, Ka-Cheung Luk, et al.
Scientific Reports
|
February 3, 2018
Development and performance of prototype serologic and molecular tests for hepatitis delta infection
Kelly E Coller, Emily K Butler, Ka-Cheung Luk, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 19, 2016
Non-invasive fibrosis score for hepatitis delta
Gunnar L Lutterkort, Anika Wranke, Cihan Yurdaydin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
May 12, 2015
Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study
Harald H Kessler, Bryan R Cobb, Heiner Wedemeyer, et al.
Therapeutic Advances in Gastroenterology
|
August 25, 2017
Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study
Benjamin Maasoumy, Birgit Bremer, Patrick Lehmann, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 62) with videos related to
Sort By:
Page
of 7
Antiviral Therapy
|
February 2, 2012
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment
Ingmar Mederacke, Cihan Yurdaydin, George N Dalekos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 1, 2018
Systemic inflammation and immune cell phenotypes are associated with neuro-psychiatric symptoms in patients with chronic inflammatory liver diseases
Amare Aregay, Meike Dirks, Verena Schlaphoff, et al.
Gut
|
April 12, 2014
Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals
Sebastian Lunemann, David F G Malone, Jan Grabowski, et al.
Gut
|
May 26, 2016
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome
Daniel Todt, Anett Gisa, Aleksandar Radonic, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 14, 2019
Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a
Franziska Rinker, Corinna M Bremer, Kathrin Schröder, et al.
Scientific Reports
|
April 2, 2020
Author Correction: Development and performance of prototype serologic and molecular tests for hepatitis delta infection
Kelly E Coller, Emily K Butler, Ka-Cheung Luk, et al.
Scientific Reports
|
February 3, 2018
Development and performance of prototype serologic and molecular tests for hepatitis delta infection
Kelly E Coller, Emily K Butler, Ka-Cheung Luk, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 19, 2016
Non-invasive fibrosis score for hepatitis delta
Gunnar L Lutterkort, Anika Wranke, Cihan Yurdaydin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
May 12, 2015
Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study
Harald H Kessler, Bryan R Cobb, Heiner Wedemeyer, et al.
Therapeutic Advances in Gastroenterology
|
August 25, 2017
Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study
Benjamin Maasoumy, Birgit Bremer, Patrick Lehmann, et al.
Page
of 7